Skip to Content

Clinical Trials

2004-0816: Phase II Trial of Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab (FOLFOX-B) for Initially Unresectable Colorectal Liver Metastases: Downstaging Followed by Hepatic Resection

2004-0874: A Phase II Study of the Combination of Bevacizumab and Erlotinib in Patients with Unresectable Hepatocellular Carcinoma

Related Care Centers

Related Diseases

© 2015 The University of Texas MD Anderson Cancer Center